|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Loans held for investment, subject to Home Equity Conversion Mortgage-Backed Securities ("HMBS") related obligations, at fair value | ||||||||||||||||||||
| Loans held for investment, subject to nonrecourse debt, at fair value | ||||||||||||||||||||
| Mortgage loans held for sale, at fair value | ||||||||||||||||||||
| Level 3 | ||||||||||||||||||||
| Fair Value, Recurring | ||||||||||||||||||||
| Total mortgage loans held for sale, at fair value | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Mortgage servicing rights ("MSR"), at fair value, $0 and $60,562 subject to nonrecourse MSR financing liability, respectively | ||||||||||||||||||||
| Fixed assets and leasehold improvements, net | ||||||||||||||||||||
| Loans, at fair value | ||||||||||||||||||||
| Loans held for investment, subject to HMBS related obligations | ||||||||||||||||||||
| Loans held for investment, subject to nonrecourse debt | ||||||||||||||||||||
| Loans Held-For-Investment | ||||||||||||||||||||
| Loans Held-For-Sale | ||||||||||||||||||||
| Total loans, at fair value | ||||||||||||||||||||
| Loans held for investment, subject to Home Equity Conversion Mortgage-Backed Securities (“HMBS”) related obligations, at fair value | ||||||||||||||||||||
| Loans held for investment, subject to nonrecourse debt, at fair value | ||||||||||||||||||||
| Loans held for investment, at fair value | ||||||||||||||||||||
| Loans held for investment, subject to nonrecourse debt | ||||||||||||||||||||
| Loans Held-For-Investment | ||||||||||||||||||||
| Total loans held for investment, at fair value | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets, net (includes $188,635 and $76,146 at fair value) | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| HMBS related obligations, at fair value | ||||||||||||||||||||
| Nonrecourse debt, at fair value | ||||||||||||||||||||
| Other financing lines of credit | ||||||||||||||||||||
| Notes payable (includes $61,156 and $53,800 at fair value, and includes $87,126 due to a related party as of both June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Payables and other liabilities (includes $4,221 and $12,547 at fair value) | ||||||||||||||||||||
| Repurchase agreement obligation, at fair value | ||||||||||||||||||||
| Fair Value, Recurring | ||||||||||||||||||||
| Total repurchase agreement obligation, at fair value | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Preferred Stock, $0.0001 par value; 600,000,000 shares authorized; 50,000 shares issued and outstanding as of both June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, value | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| TOTAL EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND EQUITY | ||||||||||||||||||||
Loading...
